Comparative advertising
Switzerland ／ Swissmedic
Statements comparing a medicinal product with other medicinal products are permitted only if they are scientifically correct and are based on equivalent clinical trials or data collections meeting the requirements of Art. 5(5), and where the studies used for the comparison rest on in vitro or animal experiments (for human medicines) this must be openly disclosed.
他の医薬品との比較に関する記載は、科学的に正確であり、かつ第5条第5項の要件を満たす同等の臨床試験またはデータ収集に基づく場合にのみ許され、ヒト用医薬品についてin vitroまたは動物実験に基づく試験を比較に用いる場合はその旨を明示しなければならない。
Note
Read in German on Fedlex. Art. 7 sits in the section on professional advertising (2. Abschnitt Fachwerbung). For advertising to the public, Art. 22 lit. c separately prohibits advertising that raises the expectation that the effect of the medicine corresponds to, or is superior to, another treatment or another medicine, so a comparative claim permissible to healthcare professionals under Art. 7 is not thereby permissible to the public. HMG Art. 31 Abs. 2 leaves the conditions for publishing price comparisons for prescription-only medicines to the Federal Council; I did not locate a price-comparison provision inside the AWV and therefore assert nothing about it.
Read in German on Fedlex. Art. 7 sits in the section on professional advertising (2. Abschnitt Fachwerbung). For advertising to the public, Art. 22 lit. c separately prohibits advertising that raises the expectation that the effect of the medicine corresponds to, or is superior to, another treatment or another medicine, so a comparative claim permissible to healthcare professionals under Art. 7 is not thereby permissible to the public. HMG Art. 31 Abs. 2 leaves the conditions for publishing price comparisons for prescription-only medicines to the Federal Council; I did not locate a price-comparison provision inside the AWV and therefore assert nothing about it.